Zilucoplan, sold under the brand name Zilbrysq, is a medication used for the treatment of generalized myasthenia gravis.[6][9][10] It is a complement inhibitor that is injected subcutaneously
| CAS No. | 1632051-40-1 |
| Molecular Weight (g/mol) | 3562.2290 |
| Molecular Formula | C172H278N24O55 |